West African Emerging Infectious Disease Research Center (WA-EIDRC)
Project Number3U01AI151812-05S1
Contact PI/Project LeaderANDERSEN, KRISTIAN GRAUGAARD Other PIs
Awardee OrganizationSCRIPPS RESEARCH INSTITUTE, THE
Description
Abstract Text
Abstract
Ensuring a world safe from microbial threats is a pressing challenge, as outbreaks exact tolls on human health, disrupt regional security, and have the potential to rapidly escalate into global crises. In recent years, severe outbreaks of Ebola, Lassa, Zika, and other emerging viruses have illustrated how vulnerable the world is to threats from RNA viral pathogens. These public health emergencies have exposed the urgent need for improved infrastructure, scientific knowledge, and diagnostic tools in areas of the world most at risk, and underscore the need for proactive pathogen surveillance, detection, and discovery. West Africa has a disproportionate vulnerability to outbreaks, but we lack awareness of acute threats, their natural history, and effective strategies for prevention. Rooted research between local and global partners, combined with novel assays and strategies for pandemic preparedness is required to answer these questions. We will build the capacity to rapidly respond to future outbreaks by establishing the West African Research Network for Infectious Diseases. This network will expand on years of successful cross-disciplinary research and capacity building, bringing together leading researchers from the United States, Liberia, Nigeria, Senegal, and Sierra Leone. We will: (1) perform comprehensive surveys of acute RNA viral disease and determine critical threats circulating in hosts and reservoirs; (2) identify risk factors of virus transmission and evolution; (3) dissect pathogenesis and natural history of severe RNA viral diseases; and (4) determine diagnostic criteria for infection outcome to guide public health interventions. Our work will significantly expand research capacity in West Africa via technology development of novel solutions for surveillance, diagnostics, and pathogen discovery. By establishing our network with a focus on priority pathogen research, technology transfer, training, and capacity building, we will develop flexible strategies for detecting, mitigating, and preventing the emergence of future infectious disease outbreaks.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: In recent years, severe outbreaks and epidemics of Ebola, Lassa, and Zika have illustrated how vulnerable the world is to threats from RNA viral pathogens. To counter the dangers posed by these viruses, we must develop flexible and scalable technologies for diagnostics, surveillance, pathogen discovery and transmission, and deploy them in the most outbreak-prone regions of the world. Here, we will establish the West African Research Network for Infectious Diseases with partners in the United States, Senegal, Sierra Leone, Liberia, and Nigeria, to develop effective strategies, and deploy the necessary tools, for detecting, mitigating, and preventing future outbreaks from emerging and re-emerging infectious diseases.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAcuteAffectAfricaAfricanAnimalsAreaAwarenessBiological AssayChiropteraClinicalClinical ManagementClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicable DiseasesCommunicationCommunitiesCountryDecentralizationDetectionDevelopmentDiagnosticDiagnostic testsDisease OutbreaksEbolaEducational workshopEmerging Communicable DiseasesEnsureEpidemicEpidemiologistEvolutionFoundationsFrequenciesFundingFutureGenomicsGoalsHealthHumanImmune responseInfectionInfectious Diseases ResearchInfrastructureKnowledgeLassaLassa virusLiberiaMetagenomicsMethodsMolecular EpidemiologyNational Institute of Allergy and Infectious DiseaseNatural HistoryNigeriaOutcomePathogenesisPatientsPersonsPrevalencePrevention strategyProtocols documentationPublic HealthRNARNA VirusesRapid diagnosticsReactionReagentResearchResearch PersonnelRiskRisk FactorsRodentSecuritySenegalSierra LeoneStandardizationSurveysSystemTechnology TransferTestingTrainingUnited StatesUnited States National Institutes of HealthViral Hemorrhagic FeversVirusVirus DiseasesWorkWorld BankZIKAcohortcomputerized toolsdata sharingdiagnostic assaydiagnostic criteriadiagnostic technologiesdiagnostic toolemerging pathogenemerging virusexperienceflexibilityfuture outbreakfuture pandemicgenome sequencingimprovedmetagenomic sequencingmicrobialnew outbreaknew technologynovelpandemic potentialpandemic preparednesspathogenpathogenic viruspreventpriority pathogenpublic health emergencypublic health interventionpublic health relevanceresponsetechnology developmenttooltransmission processviral transmission
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
781613492
UEI
PHZJFZ32NKH4
Project Start Date
21-May-2020
Project End Date
30-April-2026
Budget Start Date
01-May-2024
Budget End Date
30-April-2026
Project Funding Information for 2024
Total Funding
$819,744
Direct Costs
$739,556
Indirect Costs
$80,188
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$819,744
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U01AI151812-05S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01AI151812-05S1
Patents
No Patents information available for 3U01AI151812-05S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01AI151812-05S1
Clinical Studies
No Clinical Studies information available for 3U01AI151812-05S1
News and More
Related News Releases
No news release information available for 3U01AI151812-05S1
History
No Historical information available for 3U01AI151812-05S1
Similar Projects
No Similar Projects information available for 3U01AI151812-05S1